• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of relationship between antigen presentation and immunological tolerance on malignant tumor cells

Research Project

Project/Area Number 10670152
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Human pathology
Research InstitutionAsahikawa Medical College

Principal Investigator

MIYOKAWA Naoyuki  Asahikawa Medical College, Medical School, Associate Professor, 医学部, 助教授 (20182058)

Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥3,200,000 (Direct Cost: ¥3,200,000)
Fiscal Year 1999: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1998: ¥2,400,000 (Direct Cost: ¥2,400,000)
Keywordstumor immunity / immunological tolerance / MHC class I antigens / HSP72 / Calnexin / Grp94 / in situ RT-PCR / LOH / MHC / HLA class I / TAP / 免疫組織化学染色 / 大腸癌 / 大腸腺腫
Research Abstract

We chose 10 cases of colon cancer, 10 cases of colon cancer in adenoma and 10 cases each of colon adenomas, with mild atypia or moderate atypia or severe atypia, respectively. Using the paraffin embedded tissue sections of these cases, we analyzed antigen expression of MHC class I, TAP, HSP72, Calnexin and Grp94 molecules, which related with antigen presentation on the cell surface, by immunohistochemical staining method. The expression of MHC class I antigen decreased on cancer cells compared with normal epithelial cells. However, HSP72, Calnexin and Grp94 molecules expression increased on cancer cells. TAP antibody did not react well to paraffin embedded tissue sections. These data suggested that cancer cells at the very beginning proliferating phase might get immunological tolerance by decreasing MHC class I molecules. Next, we performed quantitative analysis of MHC class I mRNA in colon cancer cells by in situ RT-PCR method. There was no difference between colon cancer cells and normal colon epithelial cells. This suggested that MHC class I molecule expression on cell surface might not be controlled on mRNA level but on protein synthesis step or later steps. We also checked other cancer cells. Maxillary cancer cells also decreased MHC class I molecules expression. In liver cancer cells, we found many LOH (loss of heterozygosity) on various chromosomes except chromosome 6p, on which MHC gene and other MHC-related genes located.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Takahashi M, et al: "Assessment of proliferating cell nuclear antigen immunostaining in parotid tumors."Eur.Arch.Otorhinolaryngol.. 255. 311-314 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kono T, et al: "Adenosquamous carcinoma of the rectum showing endocrine cell differentiation"Dis.Colon Rectum. 42. 1089-1092 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ohsaki Y. et al: "Epidermal growth factor receptor expression cerrelates with poor prognosis in non-small cell lung caner patients with p53 overexpression"Oncology Reports. 7. 603-607 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Fujii H. et al: "Genetic classification of combined hepatocellular-cholangiocaricinoma"Human Pathology. 31. 1011-1017 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] 平田哲 他: "Nedaplatin単独投与による食道癌術前化学療法"癌と化学療法. 27. 221-226 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Takahashi M., Adachi T., Matsui R., Miyokawa N.: "Assessment of proliferating cell nuclear antigen immunostaining in parotid tumors."Eur.Arch.Otorhinolaryngol.. 255. 311-314 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kono T., Tokusashi Y., Yamamoto Y., Kakisaka A., Miyokawa N.Kasai S.: "Adenosquamous carcinoma of the rectum showing endocrine cell differentiation-Report of a case."Dis.Colon Rectum. 42 (8). 1089-1092 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Ohsaki Y., Tanno S., Fujita Y., Toyoshima E., Fujiuchi S., Nishigaki Y., Ishida S., Nagase A., Miyokawa N., Hirata S., Kikuchi K.: "Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression."Oncology Reports.. 7(3). 603-607 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Fujii H., Zhu X.G., Matsumoto T., Inagaki M., Tokusashi Y., Miyokawa N., Fukusato T., Uekusa T., Takagaki T., Kadowaki N., Shirai T.: "Genetic classification of combined hepatocellular-cholangiocarcinoma."Human Pathol.. 31. 1011-1017 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirata S., Yatsuyanagi E., Yamazaki H., Sugimoto Y., Koshiko S., Kokubo T., Atsuta Y., Sasajima T., Miyokawa N.: "Neoadjuvant chemotherapy for esophageal cancer by administration of Nedaplatin alone"Jpn.J.Cancer Chemother.. 27 (2). 221-226 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi